OmniAb, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for OABI, updated each market day.
OABI AI Sentiment
AI predicts OmniAb, Inc. Common Stock stock is likely to decrease over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About OmniAb, Inc. Common Stock
OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.
Sector
Exchange
Market Cap
$217,173,970
Cap Tier
Employees
89
Headquarters
EMERYVILLE, CA
Listed Since
Nov. 1, 2022
Website
OABI Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
OABI Volatility
OmniAb, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
